Daptomycin
41 NDCs across 18 manufacturers|41 Generic,0 Brand
Daptomycin is used to treat bacteremia and bacterial skin diseases, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 12, 2003, and the first generic was approved Sep 12, 2014. In 2024, Medicare Part D spent $121 million on Daptomycin across 153,000 claims for 35,000 beneficiaries.
Daptomycin is available as 41 NDCs from 18 manufacturers (41 generic, 0 brand), with NADAC prices from $13.42 to $23.80 per EA — a 77% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
41
41G / 0B
Manufacturers
18
competing in market
Price Spread
$13.42 – $23.80
per EA
7d Activity
avg +4.9% WoW · of 41 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Xellia Pharmaceuticals USA LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Lipopeptide Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
18 manufacturers producing DAPTOMYCIN
Frequently Asked Questions
What is Daptomycin used to treat?
Daptomycin is used to treat bacteremia and bacterial skin diseases, per the National Library of Medicine's MED-RT classification.
When did Daptomycin become available as a generic?
FDA approved the first generic Daptomycin (ANDA) on Sep 12, 2014.
How much does Medicare spend on Daptomycin?
In 2024, Medicare Part D spent $121 million on Daptomycin across 153,000 claims for 35,000 beneficiaries.
How many Daptomycin products are on the market?
The Daptomycin drug market contains 41 NDCs from 18 manufacturers — 41 generic and 0 brand products.
What is the price range for Daptomycin?
NADAC reference prices for Daptomycin range from $13.4180 to $23.7984 per EA — a 77% difference between cheapest and most expensive.
Which manufacturers make Daptomycin?
18 manufacturers list Daptomycin in NADAC. Ranked by number of NDCs, the largest are Xellia Pharmaceuticals USA LLC (5), Meitheal Pharmaceuticals Inc. (5), Sagent Pharmaceuticals (4), Hikma Pharmaceuticals USA Inc. (3), NorthStar Rx LLC (3).
How has the price of Daptomycin changed recently?
Over the past 7 days, 20 Daptomycin NDCs rose and 0 fell, with a market-wide average change of +4.9%.